PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Drs. Thomas Holland and Vance Fowler (@VanceFowler5) join Drs. Steven Tong (@syctong) and Erin McCreary (@ErinMcCreary) to discuss the ERADICATE study and the role of ceftobiprole for the treatment of complicated Staphylococcus aureus bacteremia. This session was recorded live on Tuesday, February 6th, 2024 featuring an international audience.
Thomas Holland, MD, MS
Dr. Thomas Holland completed the Global Health Fellowship Pathway in 2011 and is currently Associate Professor of Medicine at Duke University Medical Center. He is a leader in Staphylococcus aureus research and the first author on the ERADICATE Study
Vance Fowler, MD, MHS
Dr. Vance Fowler is a professor at Duke University. He has over 2 decades of continuous support as a principle investigator from the National Institutes of Health for clinical and translational research in Staphylococcus aureus and other antibiotic resistant bacterial infections and is the senior author on the ERADICATE Study
Steven Tong PhD, FRACP, MBBS (Hons), Grad Dip Epidemiol Biostats
Dr. Steven Tong is an infectious diseases physician with the Victorian Infectious Diseases Service and a lead of the Clinical and Health Systems Research Discipline at the Doherty Institute.
